Integrative human and murine multi-omics: Highlighting shared biomarkers in the neuronal ceroid lipofuscinoses

Neurobiol Dis. 2023 Nov 10:106349. doi: 10.1016/j.nbd.2023.106349. Online ahead of print.ABSTRACTNeuronal ceroid lipofuscinosis (NCL) is a group of neurodegenerative disorders whose molecular mechanisms remain largely unknown. Omics approaches are among the methods that generate new information on modifying factors and molecular signatures. Moreover, omics data integration can address the need to progressively expand knowledge around the disease and pinpoint specific proteins to promote as candidate biomarkers. In this work, we integrated a total of 62 proteomic and transcriptomic datasets originating from humans and mice, employing a new approach able to define dysregulated processes across species, stages and NCL forms. Moreover, we selected a pool of differentially expressed proteins and genes as species- and form-related biomarkers of disease status/progression and evaluated local and spatial differences in most affected brain regions. Our results offer promising targets for potential new therapeutic strategies and reinforce the hypothesis of a connection between NCLs and other forms of dementia, particularly Alzheimer's disease.PMID:37952681 | DOI:10.1016/j.nbd.2023.106349

Source: Neurobiology of Disease - November 12, 2023 Category: Neurology Authors: N Gammaldi F Pezzini E Michelucci N Di Giorgi A Simonati S Rocchiccioli F M Santorelli S Doccini Source Type: research